86 related articles for article (PubMed ID: 23785049)
21. [Application of molecular imaging to chemotherapy].
Fan W; Zhi SF; Liu JL
Ai Zheng; 2006 Jan; 25(1):122-5. PubMed ID: 16405766
[TBL] [Abstract][Full Text] [Related]
22. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
Dreussi E; Biason P; Toffoli G; Cecchin E
Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
[TBL] [Abstract][Full Text] [Related]
23. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
24. New strategies could lead to more personalized therapies for cancer.
Jones S
Pharmacogenomics; 2014 May; 15(7):901-2. PubMed ID: 24956242
[No Abstract] [Full Text] [Related]
25. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics and personalized medicine: the future for drug prescribing.
Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
[TBL] [Abstract][Full Text] [Related]
27. The paradigm of personalized therapy in oncology.
Gasparini G; Longo R
Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S7-16. PubMed ID: 22073968
[TBL] [Abstract][Full Text] [Related]
28. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
Erasmus JJ; Truong MT; Smythe WR; Munden RF; Marom EM; Rice DC; Vaporciyan AA; Walsh GL; Sabloff BS; Broemeling LD; Stevens CW; Pisters KM; Podoloff DA; Macapinlac HA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1364-70. PubMed ID: 15942579
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
30. Imaging of tumor physiology: impacts on clinical radiation oncology.
Astner ST; Shi K; Vaupel P; Molls M
Exp Oncol; 2010 Sep; 32(3):149-52. PubMed ID: 21403609
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
32. Innovation in cancer imaging.
Debergh I; Vanhove C; Ceelen W
Eur Surg Res; 2012; 48(3):121-30. PubMed ID: 22538557
[TBL] [Abstract][Full Text] [Related]
33. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic profiling joins personalized cancer medicine.
Heyn H; Méndez-González J; Esteller M
Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
[TBL] [Abstract][Full Text] [Related]
35. Imaging vascular physiology to monitor cancer treatment.
Laking GR; West C; Buckley DL; Matthews J; Price PM
Crit Rev Oncol Hematol; 2006 May; 58(2):95-113. PubMed ID: 16387510
[TBL] [Abstract][Full Text] [Related]
36. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
[TBL] [Abstract][Full Text] [Related]
37. Tumor heterogeneity as the foundation of personalized cancer treatment.
Schilsky RL
Semin Oncol; 2011 Apr; 38(2):171-2. PubMed ID: 21421107
[No Abstract] [Full Text] [Related]
38. Personalized medicine: changing the paradigm of drug development.
Couch RD; Mott BT
Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
[TBL] [Abstract][Full Text] [Related]
39. Immunomicelles for advancing personalized therapy.
Sawant RR; Jhaveri AM; Torchilin VP
Adv Drug Deliv Rev; 2012 Oct; 64(13):1436-46. PubMed ID: 22917778
[TBL] [Abstract][Full Text] [Related]
40. Mathematical modeling of systems pharmacogenomics towards personalized drug delivery. Preface.
Wu R; Wang Z
Adv Drug Deliv Rev; 2013 Jun; 65(7):903-4. PubMed ID: 23722051
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
